{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T07:16:21Z","timestamp":1724742981582},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1097\/tp.0000000000002894","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T13:46:35Z","timestamp":1564407995000},"page":"238-239","source":"Crossref","is-referenced-by-count":2,"title":["Cytomegalovirus: The \u201cTroll of Transplantation\u201d Is Now the \u201cTroll of Tolerance\u201d"],"prefix":"10.1097","volume":"104","author":[{"given":"Deepali","family":"Kumar","sequence":"first","affiliation":[{"name":"Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Selzner","sequence":"additional","affiliation":[{"name":"Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/TP.0000000000001559","article-title":"Effect of ex vivo-expanded recipient regulatory T cells on hematopoietic chimerism and kidney allograft tolerance across MHC barriers in cynomolgus macaques.","volume":"101","author":"Duran-Struuck","year":"2017","journal-title":"Transplantation"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/TP.0000000000002893","article-title":"Impact of CMV reactivation, treatment approaches and immune reconstitution in a non-myeloablative tolerance induction protocol in cynomolgus macaques.","volume":"104","author":"Alonso-Guallart","year":"2020","journal-title":"Transplantation"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2215\/CJN.13221216","article-title":"CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: a systematic review and meta-analysis of randomized, controlled trials.","volume":"12","author":"Mallat","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbmt.2019.01.012","article-title":"Effect of sirolimus exposure on the need for preemptive antiviral therapy for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.","volume":"25","author":"Guglieri-Lopez","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1111\/ajt.14754","article-title":"Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation.","volume":"18","author":"Pi\u00f1ana","year":"2018","journal-title":"Am J Transplant"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.3389\/fimmu.2018.02953","article-title":"Selective effects of mTOR inhibitor sirolimus on na\u00efve and CMV-specific T cells extending its applicable range beyond immunosuppression.","volume":"9","author":"Bak","year":"2018","journal-title":"Front Immunol"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation.","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/ciy706","article-title":"Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, phase 2 study.","volume":"68","author":"Papanicolaou","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1128\/JVI.05840-11","article-title":"Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus.","volume":"85","author":"Marsh","year":"2011","journal-title":"J Virol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:05:29Z","timestamp":1696223129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002894","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}